Pembrolizumab-Epacadostat Combination to Treat Muscle-invasive Bladder UrotheLIAl canceR: PECULIAR Study
Clinical trial NCT03832673 · WITHDRAWN
Trial details
- NCT number
- NCT03832673
- Sponsor
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-22
- Primary completion
- 2019-05-22
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.